Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China
· Delayed Price · Currency is CNY 16.93
+0.15 (0.89%)
Mar 10, 2026, 12:34 PM CST
SHE:002603 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 28,034 | 26,748 | 38,543 | 50,054 | 32,746 | 30,365 | Upgrade
|
| Market Cap Growth | 12.62% | -30.60% | -23.00% | 52.86% | 7.84% | 105.15% | Upgrade
|
| Enterprise Value | 26,114 | 27,105 | 38,844 | 48,806 | 32,890 | 28,787 | Upgrade
|
| Last Close Price | 16.78 | 15.73 | 22.25 | 28.32 | 18.31 | 16.43 | Upgrade
|
| PE Ratio | - | - | 28.50 | 21.19 | 24.37 | 24.92 | Upgrade
|
| Forward PE | 24.68 | 18.07 | 16.45 | 27.48 | 15.62 | 26.16 | Upgrade
|
| PS Ratio | 4.66 | 4.11 | 3.74 | 3.99 | 3.24 | 3.46 | Upgrade
|
| PB Ratio | 2.62 | 2.62 | 3.37 | 4.58 | 3.61 | 3.40 | Upgrade
|
| P/TBV Ratio | 2.86 | 2.87 | 3.64 | 4.90 | 3.89 | 3.60 | Upgrade
|
| P/FCF Ratio | 20.95 | 83.43 | - | 15.29 | - | 68.79 | Upgrade
|
| P/OCF Ratio | 17.89 | 43.78 | 247.93 | 14.35 | 61.94 | 19.14 | Upgrade
|
| EV/Sales Ratio | 4.34 | 4.16 | 3.77 | 3.89 | 3.25 | 3.28 | Upgrade
|
| EV/EBITDA Ratio | 90.20 | - | 18.04 | 14.82 | 17.58 | 16.99 | Upgrade
|
| EV/EBIT Ratio | - | - | 24.08 | 17.10 | 21.66 | 20.18 | Upgrade
|
| EV/FCF Ratio | 19.51 | 84.54 | - | 14.91 | - | 65.22 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.12 | 0.08 | 0.14 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | - | 0.66 | 0.26 | 0.65 | 0.16 | Upgrade
|
| Debt / FCF Ratio | 0.02 | 0.08 | - | 0.27 | - | 0.61 | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.08 | 0.02 | -0.14 | 0.02 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.85 | 3.50 | 0.13 | -0.47 | 0.10 | -0.76 | Upgrade
|
| Net Debt / FCF Ratio | -1.43 | -2.58 | -1.75 | -0.47 | -1.23 | -2.91 | Upgrade
|
| Asset Turnover | 0.39 | 0.43 | 0.62 | 0.86 | 0.83 | 0.85 | Upgrade
|
| Inventory Turnover | 1.56 | 1.66 | 1.98 | 2.47 | 2.28 | 2.23 | Upgrade
|
| Quick Ratio | 1.24 | 0.91 | 0.84 | 0.95 | 1.15 | 1.49 | Upgrade
|
| Current Ratio | 1.85 | 1.66 | 1.47 | 1.50 | 1.89 | 2.44 | Upgrade
|
| Return on Equity (ROE) | -2.58% | -6.78% | 12.02% | 23.57% | 14.91% | 14.40% | Upgrade
|
| Return on Assets (ROA) | -1.48% | -3.45% | 6.05% | 12.20% | 7.78% | 8.67% | Upgrade
|
| Return on Invested Capital (ROIC) | -4.05% | -7.94% | 12.21% | 25.97% | 15.53% | 16.67% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.30% | -7.80% | 12.90% | 24.80% | 15.30% | 15.40% | Upgrade
|
| Earnings Yield | -0.99% | -2.71% | 3.51% | 4.72% | 4.10% | 4.01% | Upgrade
|
| FCF Yield | 4.77% | 1.20% | -0.40% | 6.54% | -0.44% | 1.45% | Upgrade
|
| Dividend Yield | 3.58% | - | 1.35% | 1.77% | 1.64% | 4.35% | Upgrade
|
| Payout Ratio | - | - | 64.54% | 11.96% | 90.79% | 20.03% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | 0.01% | 0.01% | -0.01% | 0.00% | -0.35% | Upgrade
|
| Total Shareholder Return | 3.57% | 0.01% | 1.35% | 1.76% | 1.64% | 4.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.